Zhong Ze-Min, Yang Ye-Mei, Zhou Si-Tong, Hu Yong-Xuan, Mao Zu-Hao, Wu Zhong, Han Xue, Liu Kang-Xing, Hunag Shi-Yun, Hu Yan-Qing, Lu Yan, Zhou Xian-Yi
1Department of Dermatology and Venerology, Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China; 2Southern Medical University, Guangzhou 510515, China. E-mail:
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Mar 20;38(3):358-362. doi: 10.3969/j.issn.1673-4254.2018.03.19.
To evaluate the efficacy and safety of 0.9-ms 1064-nm Nd:YAG laser alone or combined with itraconazole for treatment of toenail onychomycosis.
A total of 37 patients with onychomycosis (178 toenails) were randomly assigned to groups A and B, and each group was further divided into different subgroups according to the Scoring Clinical Index of Onychomycosis (SCIO) and Onychomycosis Severity Index (OSI) scoring. All the patients were treated with 0.9-ms Nd:YAG laser once a week for 8 times. The patients in group A were treated with laser alone, and those in group B were treated with laser combined with itraconazole. The clinical effect, clinical scores, appearance of the toenails and adverse reactions in the two groups were analyzed, and the patients' satisfaction rate was also investigated.
At the 12th months of follow-up, the clinical response rate and mycological cure rate in group A were 31.33% and 30.00%, respectively, similar to the rates in group B (35.79% and 41.18%, respectively) (P>0.05). After the treatments, the SCIO and OSI scores showed no significant changes in group A (P>0.05) but both increased significantly in group B (P<0.05). The response rates did not differ significantly among the subgroups with SCIO<12 or with OSI<16 (P>0.05), but showed significant differences among the subgroups with SCIO≥12 or with OSI≥16 (P<0.05). Of the total of 178 toenails, 33.71%, 74.72% and 70.79% toenails showed improvements in terms of clear nail growth, shape and color, respectively. The overall patients' satisfaction rate was 62.16%, and no adverse reactions related with the therapy were recorded in these patients.
For treatment of toenail onychomycosis, 0.9-ms 1064-nm Nd:YAG laser can effectively improve the aesthetic appearance of the toenails, and a combined treatment with Nd:YAG laser and itraconazole can be better option in severe cases of onychomycosis.
评估0.9毫秒1064纳米掺钕钇铝石榴石(Nd:YAG)激光单独治疗或联合伊曲康唑治疗趾甲甲真菌病的疗效和安全性。
总共37例甲真菌病患者(178个趾甲)被随机分为A组和B组,每组再根据甲真菌病临床评分指数(SCIO)和甲真菌病严重程度指数(OSI)评分进一步分为不同亚组。所有患者每周接受一次0.9毫秒Nd:YAG激光治疗,共8次。A组患者仅接受激光治疗,B组患者接受激光联合伊曲康唑治疗。分析两组的临床疗效、临床评分、趾甲外观及不良反应,并调查患者的满意率。
随访12个月时,A组的临床有效率和真菌清除率分别为31.33%和30.00%,与B组(分别为35.79%和41.18%)相似(P>0.05)。治疗后,A组的SCIO和OSI评分无显著变化(P>0.05),而B组均显著升高(P<0.05)。SCIO<12或OSI<16的亚组间有效率差异无统计学意义(P>0.05),但SCIO≥12或OSI≥16的亚组间差异有统计学意义(P<0.05)。在总共178个趾甲中,分别有33.71%、74.72%和70.79%的趾甲在指甲生长、形状和颜色方面有改善。患者总体满意率为62.16%,这些患者未记录到与治疗相关的不良反应。
对于趾甲甲真菌病的治疗,0.9毫秒1064纳米Nd:YAG激光可有效改善趾甲的美观,对于严重甲真菌病病例,Nd:YAG激光联合伊曲康唑治疗可能是更好的选择。